Achilles Therapeutics's total assets for Q2 2024 were $131.19M, a decrease of -9.99% from the previous quarter. ACHL total liabilities were $15.71M for the fiscal quarter, a 2.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.